![Rory Riggs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rory Riggs
Vorstandsvorsitzender bei
CALYXT, INC.
Vermögen: 383 Mio $ am 31.05.2026
Profil
Rory Balfour Riggs was the founder of Kyntra Bio, Inc. (1993), StageZero Life Sciences Ltd. (1998) serving as Independent Director, Cibus Corp.
(2001) serving as Chairman from 2014 to 2021, Cibus, Inc. (2001) serving as Director starting 2025, eReceivables Inc. (2003) serving as Chairman from 2003 to 2014, Scientia Ventures LLC (2006) serving as General Partner, Syntax LLC (2009) serving as Chief Executive Officer from 2009 to 2023, Locus Analytics LLC (2010), Syntax Analytics LLC (2010) serving as Chief Executive Officer, and Royalty Pharma Plc (1996) serving as Independent Director.
Mr. Riggs is also the founder of Sugen, Inc.,Syntax Advisors LLC..
Mr. Riggs currently serves as Chief Executive Officer & Trustee at WEBs ETF Trust since 2017, Chairman at Cibus Ltd., Chairman at Nucelis, Inc., Director at ITI, Inc. (New York) since 2014, Director at Nuredis, Inc., and Managing Member at Balfour Venture Partners.
Former positions include President & Chief Executive Officer at The RF&P Corp.
from 1991 to 1995, Managing Director at PaineWebber, Inc. from 1981 to 1990, President, Chief Financial Officer & Director at Biomatrix, Inc. from 1996 to 2000, Independent Director at Intra-Cellular Therapies, Inc. from 2014 to 2025, Director at Sparton Corp., Patient Choice Healthcare, Inc., ChondroGene Ltd., Medrium, Inc., and Managing Member at Balfour LLC and New Ventures I LLC, Principal at Pacific Media Partners, Inc., and Associate at Strategic Planning Associates.
Education includes an MBA from The Trustees of Columbia University in The City of New York and undergraduate studies at Middlebury College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
RPI US Partners 2019 LP
 RPI US Partners 2019 LP Financial ConglomeratesFinance Functions as an investment fund 3,04 % | 20.02.2024 | 6.484.704 ( 3,04 % ) | 362 Mio $ | 31.05.2026 |
CIBUS, INC. CLASS A 28,48 % | 02.06.2026 | 14.961.421 ( 28,48 % ) | 22 Mio $ | 31.05.2026 |
Aktive Positionen von Rory Riggs
| Unternehmen | Position | Beginn |
|---|---|---|
| STAGEZERO LIFE SCIENCES LTD. | Gründer | 01.01.1998 |
| CALYXT, INC. | Vorstandsvorsitzender | 07.10.2021 |
| CALYXTPAR | Gründer | 01.01.2001 |
ITI, Inc. (New York) | Direktor/Vorstandsmitglied | 01.01.2014 |
Scientia Ventures LLC
 Scientia Ventures LLC Investment ManagersFinance Scientia Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of computational biology and chemistry, the digitization of medicine, and digital therapies as well as traditional drug development companies at the cutting edge of the life sciences. It participates in early stage transactions. | Gründer | 01.01.2006 |
Syntax Advisors LLC
 Syntax Advisors LLC Investment ManagersFinance Syntax Advisors provides investors with rules-based, diversified exposure to business risks via products that track Syntax Stratified Weight Indices. Syntax Indices are a new class of indices that reweight the most widely-used benchmarks, including the S&P 500, S&P 400, and MSCI EAFE using the Stratified Weight methodology to deliver a diversified return across all of the business opportunities in a benchmark rather than just the largest. | Vorstandsvorsitzender | - |
Cibus Ltd.
 Cibus Ltd. BiotechnologyHealth Technology Engages in the research and development of plant gene editing technology | Vorsitzender | - |
Syntax LLC
 Syntax LLC Data Processing ServicesTechnology Services Operates as financial data and technology company specializes in business classification, index construction and portfolio analysis services | Gründer | 01.05.2009 |
Nuredis, Inc.
 Nuredis, Inc. BiotechnologyHealth Technology Develops treatments for neurodegenerative and neuromuscular diseases | Direktor/Vorstandsmitglied | - |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | - |
| ░░░░ ░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ehemalige bekannte Positionen von Rory Riggs
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Rory Riggs
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
67
Beziehungen ersten Grades
32
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 32 |
|---|---|
Sparton Corp.
 Sparton Corp. Aerospace & DefenseElectronic Technology Designs and manufactures & supplies sonar system systems maritime industry | Electronic Technology |
Biomatrix, Inc.
 Biomatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets viscoelastic products | Health Technology |
Sugen, Inc.
 Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products | Health Technology |
Balfour LLC
 Balfour LLC Investment ManagersFinance Balfour participates in early-stage capital transactions and focuses on sectors such as healthcare and biotechnology. | Finance |
Patient Choice Healthcare, Inc.
 Patient Choice Healthcare, Inc. Managed Health CareHealth Services Provides medical health care plan and network services | Health Services |
ChondroGene Ltd.
 ChondroGene Ltd. Miscellaneous Commercial ServicesCommercial Services Provides genomic research services and develops therapeutic and diagnostic products for the treatment of osteoarthritis | Commercial Services |
Medrium, Inc.
 Medrium, Inc. Internet Software/ServicesTechnology Services Provides web-based billing solutions | Technology Services |
New Ventures I LLC
 New Ventures I LLC Investment ManagersFinance Functions as a venture capital fund | Finance |
Cibus Corp.
 Cibus Corp. BiotechnologyHealth Technology Operates as an agricultural technology company that develops gene edited plant traits | Health Technology |
Syntax Analytics LLC
 Syntax Analytics LLC Investment ManagersFinance Provides investment advisory services | Finance |
WEBs ETF Trust
 WEBs ETF Trust Investment Trusts/Mutual FundsMiscellaneous Provides trust services | Miscellaneous |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PaineWebber, Inc.
 PaineWebber, Inc. Investment Banks/BrokersFinance Provides stock brokerage and asset management services | Finance |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
Middlebury College
 Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pacific Media Partners, Inc. /Old/
 Pacific Media Partners, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides marketing and advertising services | Commercial Services |
StageZero Life Sciences Ltd.
 StageZero Life Sciences Ltd. Medical SpecialtiesHealth Technology Operates as a cancer diagnostics company | Health Technology |
The RF&P Corp.
 The RF&P Corp. Other Consumer ServicesConsumer Services Provides railroad transportation services | Consumer Services |
Cibus, Inc.
 Cibus, Inc. Information Technology ServicesTechnology Services Operates as an agricultural technology company | Technology Services |
Cibus Ltd.
Cibus Ltd. BiotechnologyHealth Technology Engages in the research and development of plant gene editing technology | Health Technology |
Strategic Planning Associates
 Strategic Planning Associates Investment ManagersFinance Provides investment advice | Finance |
Nucelis, Inc.
 Nucelis, Inc. Computer Processing HardwareElectronic Technology Manufacturer of biological products | Electronic Technology |
Intra-Cellular Therapies, Inc.
 Intra-Cellular Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes small molecule drugs to treat neuropsychiatric and neurological disorders | Health Technology |
ITI, Inc. (New York) | |
Locus Analytics LLC
 Locus Analytics LLC Data Processing ServicesTechnology Services Provides data analytic services | Technology Services |
Balfour Venture Partners
 Balfour Venture Partners Investment ManagersFinance Provides Investment advisory services | Finance |
Nuredis, Inc.
Nuredis, Inc. BiotechnologyHealth Technology Develops treatments for neurodegenerative and neuromuscular diseases | Health Technology |
Syntax Advisors LLC
Syntax Advisors LLC Investment ManagersFinance Syntax Advisors provides investors with rules-based, diversified exposure to business risks via products that track Syntax Stratified Weight Indices. Syntax Indices are a new class of indices that reweight the most widely-used benchmarks, including the S&P 500, S&P 400, and MSCI EAFE using the Stratified Weight methodology to deliver a diversified return across all of the business opportunities in a benchmark rather than just the largest. | Finance |
Scientia Ventures LLC
Scientia Ventures LLC Investment ManagersFinance Scientia Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of computational biology and chemistry, the digitization of medicine, and digital therapies as well as traditional drug development companies at the cutting edge of the life sciences. It participates in early stage transactions. | Finance |
Syntax LLC
Syntax LLC Data Processing ServicesTechnology Services Operates as financial data and technology company specializes in business classification, index construction and portfolio analysis services | Technology Services |
Royalty Pharma Plc
 Royalty Pharma Plc Pharmaceuticals: MajorHealth Technology Buys and operates a portfolio of biopharmaceutical royalties | Health Technology |
ERECEIVABLES INC.
 ERECEIVABLES INC. Information Technology ServicesTechnology Services Provides information technology services that simplified the handling of insurance claims appeals | Technology Services |
Wählen Sie MarketScreener 
